2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines

Aug 15, 1998·The New England Journal of Medicine·UNKNOWN Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigato

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators

Dec 3, 1998·The New England Journal of Medicine·M B LeonR E Kuntz

Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators

Sep 4, 1999·Lancet

Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study

Sep 22, 1999·Heart·F VermeerF W Bär

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

Oct 12, 1999·Circulation·E M AntmanE Braunwald

Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation

Nov 16, 1999·Circulation·D R HolmesE J Topol

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial

Dec 10, 1999·Journal of the American College of Cardiology·A M RossC F Lundergan

Catastrophic outcomes of noncardiac surgery soon after coronary stenting

Apr 12, 2000·Journal of the American College of Cardiology·G L KałuzaA E Raizner

Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study

Apr 27, 2000·European Heart Journal·P WidimskýH Suryapranata

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

Jun 7, 2000·Circulation·E BoersmaM L Simoons

The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making

Aug 11, 2000·JAMA : the Journal of the American Medical Association·E M AntmanE Braunwald

One-year survival following early revascularization for cardiogenic shock

Feb 15, 2001·JAMA : the Journal of the American Medical Association·J S HochmanUNKNOWN SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators

Feb 24, 2001·Journal of the American College of Cardiology·A B GreenbaumE M Ohman

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Jun 23, 2001·The New England Journal of Medicine·C P CannonUNKNOWN TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

Nov 22, 2001·Lancet·D A MorrowE Braunwald

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Jan 12, 2002·BMJ : British Medical Journal·UNKNOWN Antithrombotic Trialists' Collaboration

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

Jan 17, 2002·European Heart Journal·D A MorrowE Braunwald

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie

Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty

Sep 5, 2002·The American Journal of Cardiology·Simona ZormanMarko Noc

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

Jan 8, 2003·Circulation·Eberhard GrubeMary E Russell

TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation

Feb 5, 2003·Circulation·Kengo TanabeMary E Russell

American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?

Jun 20, 2003·Circulation·Raymond J GibbonsUNKNOWN American Heart Association

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

Aug 6, 2003·Circulation·Antonio ColomboUNKNOWN TAXUS II Study Group

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)

Oct 11, 2003·Lancet·Joachim SchoferUNKNOWN E-SIRIUS Investigators

Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction

Oct 15, 2003·The American Journal of Cardiology·Donald E CutlipRonald P Caputo

Predictors of hospital mortality in the global registry of acute coronary events

Oct 29, 2003·Archives of Internal Medicine·Christopher B GrangerUNKNOWN Global Registry of Acute Coronary Events Investigators

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

Jan 28, 2004·Circulation·Anthony GershlickAlan W Heldman

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

Feb 11, 2004·Circulation·David R HolmesRichard E Kuntz

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)

Mar 19, 2004·Journal of the American College of Cardiology·Erick SchampaertUNKNOWN C-SIRIUS Investigators

❮ Previous

Next ❯

Citations

[Anticoagulation in atrial fibrillation - an update].

Jan 13, 2009·Herz·Matthias AntzWolfgang Vocke

[Health-economic modeling on the use of drug-eluting stents versus coronary artery bypass graft surgery in coronary heart disease].

May 16, 2009·Herz·Vitali GorenoiAnja Hagen

[Coronary stent thrombosis: what's new in 2011?].

Apr 21, 2011·Herz·M OberhänsliS Cook

[Perioperative cardiac care for non-cardiac surgery : 2009 Guidelines of the European Society of Cardiology].

Feb 17, 2010·Der Anaesthesist·H-J Priebe, UNKNOWN European Society of Cardiology

Coronary pressure-derived fractional flow reserve in the assessment of coronary artery stenoses

Nov 28, 2012·European Radiology·Nikolaos KakourosJulie M Miller

Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry

Jan 1, 2013·Heart and Vessels·Takahide AraiKeiichi Fukuda

Antiplatelet and anticoagulant therapies in acute coronary syndromes

Dec 25, 2009·Cardiovascular Drugs and Therapy·Elias B HannaJorge F Saucedo

Practical strategies for the management of anticoagulation therapy: unsolved issues in the cardiac catheterization laboratory

Apr 15, 2010·Cardiovascular Drugs and Therapy·José G Díez, James M Wilson

Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives

Dec 3, 2011·Cardiovascular Drugs and Therapy·Francesco Iachini BellisariiRaffaele De Caterina

Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting

Mar 12, 2010·Reviews in Endocrine & Metabolic Disorders·Doron Aronson, Elazer R Edelman

Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion.

Sep 4, 2008·Journal of Thrombosis and Thrombolysis·Vijayalakshmi KunadianC Michael Gibson

Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs.

Jul 15, 2009·Journal of Thrombosis and Thrombolysis·Mark Y ChanRichard C Becker

Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction.

Jan 19, 2012·Journal of Thrombosis and Thrombolysis·Basar CandemirCetin Erol

Aging might increase myocardial ischemia / reperfusion-induced apoptosis in humans and rats.

Jun 10, 2011·Age·Miaobing LiuQian Fan

Stone management for the patient on anticoagulation.

Mar 15, 2012·Current Urology Reports·Julie M Riley, Timothy D Averch

Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease.

Jan 15, 2009·Current Treatment Options in Cardiovascular Medicine·Paul A Gurbel, Udaya S Tantry

Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding

Feb 23, 2011·Current Treatment Options in Cardiovascular Medicine·Antonio Gutierrez, Sunil V Rao

Stent thrombosis: understanding and managing a critical problem

Dec 24, 2011·Current Treatment Options in Cardiovascular Medicine·Julio F MarchiniKevin Croce

Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary intervention (J-PLACE NSTE-ACS)

Dec 7, 2013·Cardiovascular Intervention and Therapeutics·Yoshihiro MorinoMasato Nakamura

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries

Feb 7, 2009·The American Journal of Cardiology·Laurent BonelloRon Waksman

Optimal strategy of coronary revascularization in chronic kidney disease patients: a meta-analysis

Apr 23, 2013·European Journal of Internal Medicine·Yu-Yang ChenRu-Qiong Nie

Thienopyridines: time for personalized therapy?

May 26, 2009·JACC. Cardiovascular Interventions·Spencer B King, Kathryn M Momary

Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry)

Jul 25, 2009·JACC. Cardiovascular Interventions·Andrew D FrutkinUNKNOWN NCDR (National Cardiovascular Data Registry)

Perioperative management of patients with drug-eluting stents

Feb 23, 2010·JACC. Cardiovascular Interventions·Ali O Abualsaud, Mark J Eisenberg

2009 Focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology

Feb 23, 2010·JACC. Cardiovascular Interventions·Jon C GeorgeUNKNOWN American College of Cardiology

Insurance type influences the use of drug-eluting stents

Jul 24, 2010·JACC. Cardiovascular Interventions·Michael A GagliaRon Waksman

Selection of patients for drug-eluting stents based on insurance coverage: pay or don't play

Jul 24, 2010·JACC. Cardiovascular Interventions·Ronald J Krone

1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents

Aug 20, 2011·JACC. Cardiovascular Interventions·Margo KlompRobbert J de Winter

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

Sep 8, 2010·The New England Journal of Medicine·Shamir R MehtaSalim Yusuf

Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer?

May 27, 2008·European Heart Journal·Francois SchieleJean-Pierre Bassand

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents

Feb 26, 2009·European Heart Journal·Robert A ByrneAdnan Kastrati

Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry

Mar 12, 2009·European Heart Journal·Corrado TamburinoStefano De Servi

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

Nov 6, 2009·European Heart Journal·Peter BarlisCarlo di Mario

Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study

Apr 18, 2012·European Heart Journal·Yongwhi ParkPaul A Gurbel

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)

Jan 15, 2013·European Heart Journal·Marco ValgimigliUNKNOWN PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY Investigators

Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin

Oct 12, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mehmet KanbayRichard J Johnson